A nurse is caring for a client who has oligohydramnios and is undergoing a biophysical profile (BPP).

The nurse should expect to see which of the following findings on the ultrasound?

Normal level of AFP for the given gestational age.

AFP is a protein that the liver makes when its cells are growing and dividing to make new cells.

It is normally high in unborn babies and drops very low after birth.

The AFP test measures the amount of AFP present in blood and can help diagnose certain types of cancer and check how well treatment is working.

It can also help detect some birth defects in pregnant women.

Choice B is wrong because high level of AFP indicating a neural tube defect.

Neural tube defects are abnormalities that affect the brain and spinal cord of the fetus.

They can cause spina bifida, which is a condition where the spine does not close properly.

High levels of AFP can be a sign of neural tube defects, but they can also be caused by other factors, such as multiple pregnancies, inaccurate dating of pregnancy, or fetal death.

Choice C is wrong because low level of AFP indicating a chromosomal abnormality.

Chromosomal abnormalities are genetic disorders that affect the number or structure of chromosomes in the fetus.

They can cause Down syndrome, which is a condition where the fetus has an extra copy of chromosome 212.

Low levels of AFP can be a sign of chromosomal abnormalities, but they can also be caused by other factors, such as inaccurate dating of pregnancy, fetal death, or maternal obesity.

Choice D is wrong because inconclusive result, requiring further evaluation.

An inconclusive result means that the AFP level is neither too high nor too low to indicate a problem with the fetus.

It does not necessarily mean that there is something wrong with the fetus, but it may require further testing to confirm or rule out any abnormalities.

Normal ranges for AFP levels vary depending on the gestational age and the laboratory that performs the test.

Generally, the normal range for AFP levels in pregnant

A maternal serum alpha-fetoprotein test is a type of prenatal blood test that measures the levels of MSAFP in the blood of a pregnant person.The test helps the healthcare provider assess the baby’s risk of certain medical conditions, such as neural tube defects and chromosomal abnormalities.The test is usually done between 15 and 20 weeks of pregnancy.

A screening test means that it does not diagnose any health conditions, but only indicates the probability of having them.

A positive test means that the baby has a higher risk of having a birth defect, but it does not confirm it.

A negative test means that the baby has a lower risk of having a birth defect, but it does not rule it out.Further tests are needed to confirm or exclude the diagnosis.

A diagnostic test means that it can provide a definite diagnosis of a health condition.A maternal serum alpha-fetoprotein test is not a diagnostic test for spinal defects or chromosomal abnormalities in the fetus.

Statement A is wrong because it says that the test is a diagnostic test for spinal defects in the fetus, which is not true.

Statement C is wrong because it says that the test is a diagnostic test for chromosomal abnormalities in the fetus, which is not true.

Statement D is wrong because it says that the test is a screening test for chromosomal abnormalities in the fetus, which is only partially true.The test can screen for some chromosomal abnormalities, such as Down syndrome, but not all of them.

The test also screens for neural tube defects, which are not chromosomal abnormalities.

Normal ranges for MSAFP vary depending on the gestational age and the laboratory methods used.Generally, MSAFP levels increase until about 32 weeks of pregnancy and then decrease until delivery.

High levels of MSAFP may indicate neural tube defects, multiple pregnancies, incorrect dating of pregnancy, or other conditions.Low levels of MSAFP may indicate Down syndrome, other chromosomal abnormalities, or other conditions.